Cerebrolysin therapy in Rett syndrome: clinical and EEG mapping study

  title={Cerebrolysin therapy in Rett syndrome: clinical and EEG mapping study},
  author={N. Gorbachevskaya and V. Bashina and Vitali V. Gratchev and A. Iznak},
  journal={Brain and Development},
  • N. Gorbachevskaya, V. Bashina, +1 author A. Iznak
  • Published 2001
  • Medicine
  • Brain and Development
  • Based on the suggestion that nerve growth factor plays a core role in the brain maturation process, which is altered in Rett syndrome, we investigate the influence of Cerebrolysin--the brain-derived peptidergic drug - on motor and higher cortical functions in Rett syndrome girls. The open pilot study was performed on nine Rett syndrome girls (aged from 2 years and 2 months to 7 years and 6 months) at stage 3 of the illness, and included both clinical and quantitative EEG evaluations before and… CONTINUE READING
    22 Citations

    Topics from this paper

    Neurotrophic effects of Cerebrolysin in the Mecp2308/Y transgenic model of Rett syndrome
    • 17
    • PDF


    Longitudinal observation of electroencephalograms in the Rett syndrome
    • 17
    Pathophysiology of Rett syndrome from the standpoint of early catecholamine disturbance.
    • M. Segawa
    • Psychology, Medicine
    • European child & adolescent psychiatry
    • 1997
    • 20
    Morphological study of neocortical areas in Rett syndrome
    • 125
    Cerebrolysin protects isolated cortical neurons from neurodegeneration after brief histotoxic hypoxia.
    • 27